Description
The
goal of this report is to characterize, portray, and estimate the market on the
premise of sort, application, therapeutic condition, and area. It gives
point-by-point data with respect to the main considerations influencing the
development of the market. This report likewise tracks and examines aggressive
improvements of the key players regarding market advancements, item portfolios,
and financials
Request Free Sample Copy - https://www.radiantinsights.com/research/global-next-generation-sequencing-ngs-market-report-and-forecast-to-2021/request-sample
Next-Generation
Sequencing (NGS) Report by Material, Application, and Geography - Global
Forecast to 2021 is a professional and comprehensive research report on the
world's major regional market conditions, focusing on the main regions (North
America, Europe and Asia-Pacific) and the main countries (United States,
Germany, United Kingdom,Japan, South Korea and China).
In
this report, the global Next-Generation Sequencing (NGS) market is valued at
USD XX million in 2017 and is projected to reach USD XX million by the end of
2021, growing at a CAGR of XX% during the period 2017 to 2021.
The
report firstly introduced the Next-Generation Sequencing (NGS) basics:
definitions, classifications, applications and market overview; product
specifications; manufacturing processes; cost structures, raw materials and so
on. Then it analyzed the world's main region market conditions, including the
product price, profit, capacity, production, supply, demand and market growth
rate and forecast etc. In the end, the report introduced new project SWOT
analysis, investment feasibility analysis, and investment return analysis.
The
major players profiled in this report include:
• Beijing Genomics Institute
• CapitalBio Corporation
• Berry Genomics Co. Ltd
• Illumina
• Thermo Fisher Scientific
• Roche
• Qiagen
The
end users/applications and product categories analysis:
On
the basis of product, this report displays the sales volume, revenue (Million
USD), product price, market share and growth rate of each type, primarily split
into-
• Targeted Sequencing
• Exome Sequencing
• Transcriptome Sequencing
On
the basis on the end users/applications, this report focuses on the status and
outlook for major applications/end users, sales volume, market share and growth
rate of Next-Generation Sequencing (NGS) for each application, including-
• Genome Sequencing
• Genome Resequencing
• DNA-protein Interactions
(ChIP-sequencing)
View Full Report at- https://www.radiantinsights.com/research/global-next-generation-sequencing-ngs-market-report-and-forecast-to-2021
This
report is a total investigation of ebb and flow inclines in the market,
business development drivers, and restrictions. It gives showcase projections
to the coming years. It incorporates investigation of late advancements in
innovation, Doorman's five power demonstrate examination and point by point
profiles of best industry players. The report additionally incorporates a
survey of miniaturized scale and large-scale factors fundamental for the
current market players and new participants alongside nitty gritty esteem chain
examination
About Us
Radiant
Insights is a market research and consulting company offering syndicated
research studies, customized reports, and consulting services. Our market
research studies are designed to facilitate strategic decision making, on the
basis of extensive and in-depth quantitative information, supported by
extensive analysis and industry insights. Using a patented and robust research
methodology, we publish exhaustive research reports covering a host of
industries such as Technology, Chemicals, Materials, and Energy. Radiant
Insights has a strong base of analysts, consultants and domain experts, with
global experience helping us deliver excellence in all research projects we
undertake
Contact Us
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
201
Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel:
1-415-349-0054
Toll
Free: 1-888-928-9744
No comments:
Post a Comment